Oocyte cryopreservation is important for assisted reproductive technologies (ART). Although cryopreservation of metaphase II (MII) oocytes has been successfully used, MII oocytes are vulnerable to the damage inflicted by the freezing procedure. Cryopreservation of germinal vesicle stage oocytes (GV-oocytes) is an alternative choice; however, blastocyst development from GV-oocytes is limited largely due to the need for in vitro maturation (IVM). Herein, we evaluated the effects of L-carnitine (LC) supplementation during vitrification and thawing of mouse GV-oocytes, IVM, and embryo culture on preimplantation development after in vitro fertilization (IVF). We first compared the rate of embryonic development from the oocytes that had been collected at the GV stage from three mouse strains, (B6.DBA)F1, (B6.C3H)F1, and B6, and processed for IVM and IVF, as well as that from the oocytes matured in vivo, i.e. ovulated (IVO). Our results demonstrated that the rate of blastocyst development was the highest in the (B6.DBA)F1 strain and the lowest in the B6 strain. We then supplemented the IVM medium with 0.6 mg/ml LC. The rate of blastocyst development improved in the B6 but not in the (B6.DBA)F1 strain. Vitrification of GV-oocytes in the basic medium alone reduced the rate of blastocyst development in both of those mouse strains. LC supplementation to the IVM medium alone did not change the percentage of blastocyst development. However, LC supplementation to both vitrification and IVM media significantly improved blastocyst development to the levels comparable with those obtained from vitrified/thawed IVO oocytes in both of the (B6.DBA)F1 and B6 strains. We conclude that LC supplementation during vitrification is particularly efficient in improving the preimplantation development from the GV-oocytes that otherwise have lower developmental competence in culture.
INTRODUCTION
Infertility is common in the human population, ranging from 5% to 15% [1] . In vitro fertilization (IVF) of the oocytes at the second metaphase (MII) obtained from women after ovarian stimulation has been widely practiced as an assisted reproductive technology (ART) [2] . Following in vitro culture (IVC) of IVF oocytes, only one or two embryos are transferred to the women in each treatment cycle, while most of the remaining embryos are preserved for future use. Cryopreservation of embryos, particularly at the blastocyst stage, has been used successfully to produce healthy babies [3] . However, this technique is not an option for women who face a risk of infertility such as cancer therapy and do not yet have male partners [4] . In some countries, embryo cryopreservation is prohibited due to ethical and legal constraints. Furthermore, cryopreservation of unfertilized oocytes would offer flexibility in the time of infertility treatment or establishment of an oocyte banking program. Finally, oocyte preservation has potential applications for livestock breeding, research, and conservation of rare or endangered species [5] [6] [7] [8] . Following the first successful cryopreservation of mammalian oocytes at MII in the mouse [9] and rat [10] , the first human baby was reportedly born from a cryopreserved MII oocyte in 1986 [11] . Although numerous studies have been reported in the field of oocyte cryopreservation, and more than 1000 healthy babies have been born from cryopreserved MII oocytes [12] since then, the overall success in reproduction from cryopreserved oocytes remains lower than when fresh oocytes are used [13] . Several factors appear to be associated with this limited success, including large size, low volume-to-surface ratio, high lipid contents, and the nature of the plasma membrane of the oocyte [14] [15] [16] . Although mainly two techniques, slow-rate freezing and vitrification, have been used for cryopreservation of oocytes in different species [5À7, 17À23], vitrification has been the favorite in recent years because it results in less damage to the oocyte [24, 25] .
Until now, most attempts to cryopreserve oocytes used the oocytes at the MII stage. However, MII oocytes are prone to cryopreservation damage such as meiotic spindle disorganization [21, 26] , microfilament disruption [27, 28] , and premature cortical granules release [29] . Cryopreservation of oocytes at the germinal vesicle (GV) stage can circumvent these problems. Furthermore, collection of oocytes at the GV stage has many clinical advantages, such as reducing the risk of ovarian hyperstimulation syndrome, minimizing the cost and duration of hormonal treatment, and allowing the oocytes to be preserved in ovarian tissues [30] [31] [32] . However, oocytes collected at the GV stage require in vitro maturation (IVM), which diminishes their competence for embryonic development [20, 33, 34] . Attempts have been made to cryopreserve GV-stage oocytes (GV-oocytes) [5À6, 20, 33À34] , and successful production of live offspring from frozen GVoocytes has been reported in both humans and mice [30, 35] . Nonetheless, most of the oocytes cryopreserved at the GV stage fail in reaching the blastocyst stage [35, 36] . Improvement in the conditions for both cryopreservation and IVM is imperative to make cryopreservation of GV-oocytes optimal for clinical applications.
L-carnitine (LC; b-hydroxy-c-trimethylammonium-butyric acid), a water-soluble small molecule, is known to play an essential role in fat metabolism. This molecule is crucial for the normal mitochondrial oxidative processing of fatty acids and the release of acyl-COA esters, and consequently influences ATP levels in the cells (reviewed by [37] ). It also has antioxidant activity to protect the cells from DNA damage [38] . Beneficial effects of LC on embryonic development in culture have been reported in many mammalian species. In mice, supplementation of the IVM medium with LC improves spindle microtubule assembly and chromosome alignment in MII oocytes, and it increases subsequent embryonic development through reduction of apoptosis [39] [40] [41] . In cattle, LC promotes relocation of active mitochondria to the inner oocyte membrane and, thus, subsequent embryonic development [42] . Moreover, LC supplementation improves lipid metabolism in bovine embryos and increases the cryotolerance of blastocyst embryos [43] . In pigs, LC improves nuclear maturation in oocytes and increases embryonic cleavage rates, which are associated with an enhancement in mitochondrial activity and a decrease in intracellular lipid contents and H 2 O 2 levels [44] [45] [46] .
The double role of LC as an antioxidant and an essential component of lipid metabolism makes it a candidate as a novel noninvasive agent for improving oocyte cryopreservation efficiency and subsequent embryonic development. However, no study has reported the effect of LC on the oocyte during vitrification and thawing. The aim of the present study was to investigate the effect of LC supplementation during vitrification and thawing of mouse GV-oocytes surrounded by cumulus cells (cumulus-oocyte complexes [COCs]), followed by IVM and IVF, on subsequent preimplantation embryonic development.
MATERIALS AND METHODS

Reagents
All chemicals were purchased from Sigma Chemical Co. unless otherwise stated.
Animals
All experiments were carried out according to the Guide to the Care and Use of Experimental Animals released by the Canadian Council on Animal Care and with approval from the Animal Care Committee at McGill University. C57BL/6 (B6) females were purchased from the Jackson Laboratory and crossed with DBA or C3H males (Charles River) to produce (B6.DBA)F1 and (B6.C3H)F1 progeny in our mouse colony. All animals were maintained under specific-pathogen-free conditions with a humidity range of 30%-60%, a temperature range of 218À248C, and a light cycle of 12L:12D, and the food and water were provided ad libitum.
Collection of COCs and IVM
Females (8-10 wk old) were i.p. injected with 5 IU equine chorionic gonadotropin (eCG) each. The females were euthanized 45À47 h later by cervical dislocation, and the ovaries were dissected. COCs were obtained by puncturing antral follicles using a pair of 26 G needles. The oocytes were collected in minimum essential medium, alpha modification (MEM-alpha; Gibco) supplemented with 5% fetal bovine serum (FBS; Gibco), 50 lg/ml streptomycin, and 75 lg/ml penicillin G potassium salt. The COCs were then subjected to either vitrification or IVM. For IVM, groups of 10À15 COCs were cultured in prewarmed 50-ll droplets of the maturation medium (MEM-alpha supplemented with 5% FBS, 25 lg/ml pyruvate, 300 ng/ml follicle-stimulating hormone, 50 lg/ml streptomycin, and 75 lg/ml penicillin G potassium salt) under mineral oil for 16 h at 378C with 5% CO 2 in a humidified atmosphere.
For collection of in vivo-matured (IVO) oocytes, females (8-10 wk old) were injected with 5 IU eCG each, followed 45-47 h later by injection with 5 IU human chorionic gonadotropin. COCs were collected 14-15 h later from the ampullar regions of the oviducts.
Sperm Preparation, IVF, and Embryo Culture
Sperm were collected from 10-to 12-wk-old (B6.DBA)F1 males. Spermatozoa were allowed to swim out of the epididymis into a droplet of 300 ll prewarmed sperm-capacitating medium (MEM-alpha supplemented with 0.9% bovine serum albumin [BSA] ) and covered with mineral oil. Then, the medium containing sperm was incubated for 60 min at 378C with 5% CO 2 in a humidified incubator for sperm capacitation. IVF was performed according to the method described by Vasudevan et al. [47] with some modifications. Briefly, IVM or IVO COCs were washed once with the IVF medium (MEMalpha supplemented with 0.4% BSA), then groups of 10À15 COCs were transferred to 50-ll droplets of prewarmed IVF medium under mineral oil. Ten microliters of capacitated spermatozoa was added to each microdrop of IVF medium containing COCs, which was further incubated for 5 h at 378C with 5% CO 2 in a humidified atmosphere. Inseminated oocytes were then thoroughly washed to remove adhered spermatozoa and cumulus cells by repeating pipetting. The fertilized eggs were cultured in modified KSOMaa (potassium simplex optimization medium with amino acids) [28] for up to 4 days (Day 0 ¼ day of insemination) at 378C under 5% CO 2 in humidified atmosphere. At 24 h postinsemination (pi), the numbers of oocytes that developed to the two-cell stage were recorded, and the uncleaved oocytes were separated into different droplets. The number of blastocyst embryos was recorded at 4 days pi, and its ratio was calculated against the number of twocell-stage embryos. Blastocysts were stained by 10 lg/ml Hoechst 33342 to evaluate cell numbers.
Vitrification and Warming
For vitrification, we used the cryoloop method as previously described by Lane et al. [48] . The cryoloop device comprises a nylon loop (20 lm wide; 0.5À0.7 mm diameter) and a stainless steel tube inserted into a lid of cryovial. The cryoloops were mounted with expoxide into the vials (Hampton Research). The base medium (BM) used for preparation of vitrification and warming solutions was MEM-alpha supplemented with 10% FBS. COCs from (B6.DBA)F1, (B6.C3H)F1, or B6 females were transferred into 500 ll of equilibration solution (BM supplemented with 7.5% v/v ethylene glycol [EG], 7.5% dimethylsulfoxide [DMSO, and 0.25 M trehalose]). COCs were maintained in this solution for 3 min and transferred into a 20-ll droplet of vitrification solution (BM supplemented with 15% v/v EG and 15% v/v DMSO). Then, the cryoloop was dipped into the vitrification solution so that a thin film was formed by surface tension. Three to five COCs were gently placed on the film using a glass mouth pipette and directly plunged into a cryovial that had been submerged and filled with liquid nitrogen (LN 2 ). The cap was then tightened and the vial was returned to LN 2. The whole process was preformed within less than 1 min. To warm the vitrified COCs, the cap of the cryovial submerged in LN 2 was carefully unscrewed and opened. The cryoloop containing vitrified COCs was immediately transferred into 1 ml warming solution (BM supplemented with 1 M trehalose). The COCs fell into the medium, which was kept warm for 3 min, and were then transferred into 500 ll BM supplemented with 0.5 M trehalose and then to BM alone for 3 min each. All the thawing procedures were conducted at 378C. Finally, the COCs were examined morphologically to assess their viability. Oocytes with a spherical and symmetrical shape, containing evenly granulated cytoplasm, were regarded as viable, whereas oocytes with apparent membrane damage, degenerated cytoplasm, or loss of cumulus cells were regarded as nonviable. Viable COCs were subjected to IVM as described earlier. IVO COCs were similarly vitrified/ thawed and morphologically examined.
LC Supplementation
LC was dissolved in the BM or IVM medium at a final concentration 0.6 mg/ml and sterilized by filtration.
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Statistical Analysis
At least 20 oocytes were examined in each experimental group, and experiments were repeated at least three times. Data were pooled and analyzed by chi-square test. All results were considered to be statistically significant at P , 0.05.
RESULTS
Effect of the Mouse Genetic Background on Oocyte Maturation and Embryonic Development In Vitro
We compared the rate of embryonic development from the oocytes that had been collected from three mouse strains, (B6.DBA)F1, (B6.C3H)F1, and B6, and processed for IVM and IVF, as well as that from the IVO oocytes (Fig. 1) . No significant difference was observed in the cleavage rates at 24 h pi between IVM and IVO oocytes within each mouse strain. The percentage of blastocyst development from IVM oocytes at 4 days pi was significantly lower than that from IVO oocytes within each mouse strain. Among the three mouse strains, no difference was found in the cleavage rates of IVM oocytes, whereas the cleavage rate of IVO oocytes of (B6.C3H)F1 was significantly lower than that of IVO occytes of (B6.DBA)F1 (P, 0.05). No difference was found between IVO oocytes of B6 and (B6.DBA)F1 or B6 and (B6.C3H)F1. The percentage of blastocyst development from IVM oocytes of (B6.DBA)F1 was significantly higher than that of (B6.C3H)F1 or B6 IVM oocytes (P , 0.05 and P , 0.01, respectively). No difference was found between IVM oocytes of (B6.C3H)F1 and B6. The percentages of blastocyst development from IVO oocytes were comparable between (B6.DBA)F1 and (B6.C3H)F1, which were higher than that for IVO oocytes of B6. Overall, preimplantation development from either IVM or IVO oocytes was the highest in the (B6.DBA)F1 strain, the middle in the (B6.C3H)F1 strain, and the lowest in the B6 strain. Accordingly, we have chosen (B6.DBA)F1 and B6 strains as the models for oocytes with high and low developmental competence, respectively, in the following experiments.
Effects of LC Supplementation During Oocyte IVM on Subsequent Preimplantation Development
We examined the effects of LC supplemented in the IVM medium on preimplantation embryonic development from GVoocytes. The oocytes in COCs from (B6.DBA)F1 or B6 females were matured in vitro in the IVM medium either 
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supplemented with or without 0.6 mg/ml LC, followed by IVF and embryonic development. While no significant difference was found for the (B6.DBA)F1 strain, the percentage of blastocyst embryo development was significantly higher (P , 0.05) in the oocytes matured in the presences of LC than those matured in the basic medium for the B6 strain (Fig. 2) . LC supplementation did not affect the cleavage rate in either strain. Our preliminary experiments using different concentrations of LC (0.3, 0.6, or 1 mg/ml) in the IVM medium showed that LC at 0.3 mg/ml had no effect, LC at 0.6 mg/ml improved blastocyst development, and LC at 1 mg/ml was inhibitory (not shown). We also tested the effects of LC supplementation in the medium during embryo culture but did not find any difference (not shown).
Effects of LC Supplementation During Vitrification and Thawing of COCs on the Survival Rates
Next, we examined the effects of LC supplementation during vitrification and thawing of GV-oocytes within COCs collected from (B6.DBA)F1 and B6 strains on their viability. As shown in Figure 3 , survival rates of oocytes (based on morphology) were over 90% with or without LC supplementation in both mouse strains. We also examined the survival rates of IVO oocytes after vitrification and thawing, which were also over 90% for both strains.
Effects of LC Supplementation Throughout Vitrification, Thawing, and IVM of Oocytes in COCs on Subsequent Preimplantation Development
Vitrification of either GV-or IVO oocytes reduced cleavage rate and blastocyst development in both (B6.DBA)F1 and B6 strains (Fig. 4) . Particularly, no or very few blastocyst embryos were obtained from the vitrified GV-oocytes of B6. Supplementation of LC during IVM alone did not change the percentage of blastocyst development, whereas supplementation of LC throughout vitrification, thawing, and IVM significantly increased (P , 0.05) the percentage of blastocyst embryo development in both strains. These percentages were 
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comparable to those obtained from vitrified/thawed IVO oocytes. No differences were found in the cleavage rates. We counted the cell numbers of blastocyst embryos, but found no difference between different groups (data not shown).
DISCUSSION
The current study demonstrates for the first time that supplementation of LC during both vitrification and IVM improves preimplantation development from vitrified GVoocytes in COCs in both (B6.DBA)F1 and B6 mouse strains. On the other hand, supplementation of LC in the IVM medium alone showed no effect on the preimplantation development from vitrified oocytes and improved the preimplantation development from GV-oocytes in COCs without vitrification in the B6 strain but not in the (B6.DBA)F1 strain. Therefore, the beneficial effects of LC supplementation during vitrification are more prominent than those during IVM. Moreover, the oocytes that are less competent for embryonic development in vitro appear to be more responsive to an improvement in either vitrification or IVM conditions.
Influence of the Genetic Background on Preimplantation Development from Oocytes Matured In Vivo or In Vitro
It is well documented that the genetic background affects reproductive performance in mice [49] , particularly preimplantation development in culture [50] . It has also been reported that the frequency of nuclear maturation (i.e., MII) in the oocytes in vivo or in vitro varies depending on the genetic background [51] . Additionally, the survival rates of embryos, sperm, and oocytes after cryopreservation are affected by the genetic background [52] [53] [54] .
In the present study, we compared the cleavage rate and blastocyst development following IVF of IVM or IVO oocytes in three different mouse strains, (B6.DBA)F1, (B6.C3H)F1, and B6, which are commonly used in reproductive biology research and transgenic technology. Our results demonstrated that the percentages of blastocyst development were significantly lower in IVM oocytes than those in IVO oocytes in all examined strains, in agreement with previous reports in many mammalian species [55] [56] [57] [58] . Several parameters have been reported to differ in IVM versus IVO oocytes, such as mitochondria and ATP contents [59] , glutathione contents [60] , protein synthesis [61] , and translation efficiency [62] .
Among the three mouse strains examined, the highest percentage of blastocyst development was obtained from the oocytes of (B6.DBA)F1 and the lowest from the oocytes of B6. In general, it is well known that the oocytes of F1 hybrid mice perform well in culture. However, our results also showed that blastocyst development from the oocytes of (B6.C3H)F1 was significantly lower than that of (B6.DBA)F1, indicating that the success of preimplantation development depends on the individual genetic background, not just on the F1 hybrid background. It is also known that gametes and embryos produced from B6 mice are extremely sensitive to in vitro manipulations [63] , and their developmental potential is lower than many other strains [64] . Furthermore, due to low oolemma healing capacity, the oocytes of B6 are particularly fragile during intracytoplasmic sperm injection [65] . The differences in the success rates of oocyte maturation and embryo development among mouse strains have been ascribed to the variations in the synthesis of key regulatory cell cycle factors such as cyclins [66] , c-mos [67] , and cdc25b [68] . In our study, however, the success rate of maturation or fertilization of the GV-oocytes of B6, based on cleavage rates, did not differ from that of (B6.DBA)F1. On the other hand, the success rate of blastocyst development from B6 oocytes after IVM or vitrification was consistently lower than that of (B6.DBA)F1.
Improvement in Preimplantation Development from IVM Oocytes with LC Supplementation
The beneficial effects of LC during IVM and embryo culture has been reported in many mammalian species. In mice, supplementation of the IVM medium with 1 mM LC increases b-oxidation and the rates of nuclear maturation, fertilization, and blastocyst development [40, 41] . Furthermore, incubation of mouse MII oocytes and embryos with peritoneal fluid collected from women who suffer from endometrioses significantly increases the proportions of oocytes with damaged microtubules and chromosomes and also elevates the level of apoptosis in embryos compared to control groups; however, addition of 0.6 mg/ml LC during culture reverses this effect [39] . In pigs, supplementation of IVM medium with 0.5À0.6 mg/ml LC increases oocyte maturation and cleavage rates [44] and blastocyst development [45, 46] . In cattle, supplementation of embryo culture medium with 1.5À3.0 mM LC improves blastocyst development rate [43] . These beneficial effects of LC have been attributed to its roles as an antioxidant, enhancer of mitochondrial lipid metabolism, and increaser of ATP contents and glutathione levels.
All previous reports in mice each used only one mouse strain to evaluate the effects of LC. In the present study, we compared the effects of LC on blastocyst development from IVM oocytes of (B6.DBA)F1 and B6. The results showed that supplementation of the IVM medium with 0.6 mg/ml LC significantly improved preimplantation development from B6 oocytes compared to that without LC supplementation. However, such effects were not found for (B6.DBA)F1 oocytes. We speculate that B6 oocytes, which were more susceptible to in vitro conditions, were better benefited by LC supplementation compared to (B6.DBA)F1 oocytes.
Improvement of Preimplantation Development from Vitrified/Thawed Oocytes at the GV Stage with LC Supplementation
Cryopreservation of gametes and embryos is considered to be one approach to preserving fertility in both humans and animal species. Despite extensive attempts, the efficiency of oocyte cryopreservation in terms of blastocyst development remains low [13] . Many factors have been shown to influence the efficiency of oocyte cryopreservation. Among these factors, the meiotic stage of oocytes at the time of cryopreservation can affect the developmental potential of cryopreserved oocytes. However, the results have been controversial. Some reports claim that cryopreservation of mouse oocytes at the GV stage results in lower developmental success compared to that of oocytes at the MII stage [69] . On the other hand, other studies show that cryopreservation of oocytes at the GV stage leads to better outcomes than that of oocytes at the MII stage [70À72]. The latter results were explained in that cryopreservation of oocytes at the GV stage circumvents the problems associated with the spindle cryodamage inflicted by freezing of MII oocytes [7, 71, 72] . However, the clinical application of GVoocyte cryopreservation is limited due to the requirement of IVM, which is known to diminish the developmental competence of oocytes. Thus, improvement in both cryopreservation and IVM conditions will make cryopreservation of GV-oocytes more clinically applicable for assisted reproduction and fertility preservation in women.
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In the present study, we demonstrated that LC supplementation during vitrification and IVM of GV-oocytes in COCs improved their preimplantation development in both (B6.DBA)F1 and B6 mouse strains. To our best knowledge, this is the first report to compare the developmental potential of vitrified/thawed GV-oocytes in two mouse strains. Until now, most oocyte cryopreservation studies have been devised using F1 hybrid and outbred ICR mice, and few studies have been done using the B6 strain. Hybrid (B6.DBA)F1 mice are strong and vigorous and have excellent reproductive performance in vitro. As we discussed earlier, on the other hand, oocytes and embryos from B6 mice are more vulnerable to manipulations in vitro, although they are as fertile as F1 mice in vivo. However, the B6 mouse strain is commonly used in reproductive biology research, and many mutations are available on this genetic background. The improvement in developmental competence of B6 oocytes after vitrification would be an asset for a wide variety of biological studies. Furthermore, the low developmental competence of B6 oocytes may be a better model for human ART cases in which the quality of oocytes is compromised by ageing or pathological conditions such as diabetes and obesity.
Our results show that the percentage of blastocyst development from the oocytes vitrified at the GV stage in COCs and matured in the basic medium (without LC) was significantly lower than vitrified/thawed IVO oocytes, despite similar survival rates (over 90%). LC supplementation in the IVM medium alone did not change the blastocyst development from vitrified GV-oocytes in COCs. However, LC supplementation during both vitrification and IVM significantly improved blastocyst development to the levels comparable with those obtained from vitrified/thawed IVO oocytes. These results were consistent in both (B6.DBA)F1 and B6 strains. We must emphasize that while no or very few blastocyst embryos were developed from vitrified/thawed GV-oocytes of B6 without LC supplementation, 20% of blastocyst development occurred with LC supplementation. The low developmental competence of the oocytes that had been vitrified and matured in the basic medium can be attributed to the damage on certain cytoplasmic components, which may influence oocyte maturation and embryonic development [21] . In addition, it has been reported that vitrification of GV-oocytes causes damage to their surrounding cumulus cells, which consequently disrupts their communication with the enclosed oocyte [20] . This communication is crucial for successful completion of IVM and subsequent embryonic development [73] . Our results suggest that this damage can be avoided by LC supplementation during both vitrification and IVM. Since we cultured oocytes surrounded by cumulus cells until IVF, we cannot rule out the possibility that LC acted on cumulus cells. However, we did not observe any difference in cumulus cell expansion at the end of IVM with or without LC supplementation. Further studies are needed to identify the role of LC in the protection of oocytes from cryodamage.
The present study suggests that both genetic backgrounds and culture conditions have an impact on developmental competence of vitrified/thawed mouse GV-oocytes in COCs. Developmental potential of mouse oocytes following IVM/IVF or IVO/IVF was the highest in the (B6.DBA)F1 strain and the lowest in the B6 strain. Supplementation of LC to the IVM medium improved blastocyst development following IVF in the B6 but not in (B6.DBA)F1 strain. Our results demonstrate for the first time that LC supplementation during vitrification and IVM of GV-oocytes in COCs improved preimplantation development to levels comparable with those of vitrified/ thawed IVO oocytes in both B6 and (B6.DBA)F1 strains. It remains to be tested whether the improvement in blastocyst embryo development results in healthy pups. These results have a potential for improving the clinical trials of human GVoocytes for cryopreservation and IVM in ART.
